Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Acrocephalosyndactylia × pemigatinib × Thoracic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 2 Thoracic 1 Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 3 Breast Neoplasms 2 Stomach Neoplasms 1 Sarcoma 1 Recurrence 1 Lung Neoplasms 1 Gastrointestinal Neoplasms 1 Carcinoma, Transitional Cell 1 Carcinoma 1 Advanced Non-Small Cell Lung Cancer 1 Advanced Non Small Cell Lung Cancer 1 Acrocephalosyndactylia 1

Interventions

pemigatinib 1 erdafitinib 1 Rogaratinib 1 INCB 54828-101 1 Drug Combinations 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05253807 2025-08-05

FIGHT-210

Incyte Corporation

Phase 2 Completed

8 enrolled 13 charts

Acrocephalosyndactylia, Carcinoma, Non-Small-Cell Lung, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡